Bausch Health Companies Stock
Bausch Health Companies Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Thomas J. Appio
- Employees
- 20,300
- Market cap
- $2.4 B
- IPO
- 29/03/1994
Bausch Health Companies Inc. is a healthcare company based in Laval, Canada, engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. The company is traded on the NYSE and was formerly known as Valeant…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Bausch Health Companies stock: price history
1D
-0.2%
1W
+4.3%
1M
+10.7%
6M
+6.8%
YTD
-9.4%
1Y
+4.8%
2Y
-25.5%
5Y
-77.9%
10Y
-71.5%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~71% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Bausch Health Companies
Analyst assessment of Bausch Health Companies
PRICE TARGET LOW
US$9.00
CONSENSUS
US$9.00
MEDIAN
US$9.00
PRICE TARGET HIGH
US$9.00
0
STRONG BUY
19
BUY
15
HOLD
4
SELL
0
STRONG SELL
38
TOTAL · Buy
As of: 27/04/2026
Bausch Health Companies stock metrics
P/E
-2.14
P/B
-1.33
EV/EBITDA
10.41
RETURN ON EQUITY
-14.6%
NET MARGIN
9.0%
DEBT/EQUITY
-11.73
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
88.6%
FLOAT SHARES
331,339,189
AVG. DAILY VOLUME (30D)
1,958,530
Insider transactions (SEC)
Paulson John
LEUNG SANDRA
WECHSLER AMY B
Lenar Aimee J.
Lenar Aimee J.
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Bausch Health Companies stock
What does Bausch Health Companies do?
Bausch Health Companies Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Thomas J. Appio, the company employs around 20,300 people.
The IPO was on 29/03/1994; the stock trades on NYSE under the ticker BHC.
What do analysts say about Bausch Health Companies stock?
38 analysts rate the stock, the consensus is Buy (as of 27/04/2026).
The average price target is US$9.00, ranging from US$9.00 to US$9.00, with a median of US$9.00.
This is an external assessment, not a statement by Market Jury.
When does Bausch Health Companies report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 71% stronger than usual.
Does Bausch Health Companies pay a dividend?
Yes. The last dividend was US$1.00 per share, ex-date 10/11/2010, paid on 22/12/2010.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Bausch Health Companies?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Bausch Health Companies stock analyzed?
Clicking "Analyze stock" lets five strategies assess Bausch Health Companies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.